Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,200Revenue (TTM) $M105Net Margin (%)11.2Altman Z-Score6.9
Enterprise Value $M1,153EPS (TTM) $0.3Operating Margin %15.3Piotroski F-Score5
P/E(ttm)107Beneish M-Score-2.6Pre-tax Margin (%)11.2Higher ROA y-yY
Price/Book7.110-y EBITDA Growth Rate %--Quick Ratio7.6Cash flow > EarningsN
Price/Sales11.55-y EBITDA Growth Rate %40.6Current Ratio8.7Lower Leverage y-yN
Price/Free Cash Flow384y-y EBITDA Growth Rate %13.4ROA % (ttm)5.1Higher Current Ratio y-yY
Dividend Yield %--PEG2.6ROE % (ttm)7.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.9ROIC % (ttm)22.7Gross Margin Increase y-yN

Gurus Latest Trades with RGEN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RGEN is held by these investors:



RGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAWES KAREN ADirector 2017-03-21Sell2,521$34.123.46view
Benjamin HowardVP Business Development 2017-03-20Sell12,216$34.621.96view
RYAN THOMAS F JRDirector 2017-03-20Sell4,000$34.831.35view
Snodgres JonCFO 2017-03-17Sell1,909$34.911.12view
Hunt AnthonyCEO 2016-11-28Sell5,000$33.126.58view
RYAN THOMAS F JRDirector 2016-09-14Sell2,700$32.588.35view
RYAN THOMAS F JRDirector 2016-06-30Sell5,000$26.632.71view
RYAN THOMAS F JRDirector 2016-06-28Sell10,000$24.5943.55view
Benjamin HowardVP Business Development 2016-05-11Sell2,889$26.7232.11view
Benjamin HowardVP Business Development 2015-06-09Sell35,000$38.14-7.45view

Quarterly/Annual Reports about RGEN:

News about RGEN:

Articles On GuruFocus.com
Repligen to Report First Quarter 2017 Financial Results Apr 21 2017 
Repligen Corp. Reports Operating Results (10-Q) Feb 09 2011 
Repligen Corp. Reports Operating Results (10-Q) Nov 02 2010 
Repligen Corp. Reports Operating Results (10-Q) Aug 05 2010 
Repligen Corp. Reports Operating Results (10-Q) Feb 04 2010 
Repligen Corp. Reports Operating Results (10-Q) Nov 05 2009 
Repligen Corp. Reports Operating Results (10-Q) Feb 06 2009 

More From Other Websites
ETFs with exposure to Repligen Corp. : April 21, 2017 Apr 21 2017
Repligen to Report First Quarter 2017 Financial Results Apr 21 2017
Stocks Flat But Alphabet, Lockheed Martin Hit New Highs Mar 17 2017
Top 3 Healthcare Penny Stocks for 2017 Mar 01 2017
Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Feb 23 2017
Edited Transcript of RGEN earnings conference call or presentation 22-Feb-17 1:30pm GMT Feb 22 2017
Repligen beats 4Q profit forecasts Feb 22 2017
Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017 Feb 22 2017
Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : February 21, 2017 Feb 21 2017
Repligen To Report Fourth Quarter and Full Year 2016 Financial Results, Provides Financial Guidance... Feb 16 2017
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin... Jan 04 2017
Repligen Corp. – Value Analysis (NASDAQ:RGEN) : January 3, 2017 Jan 03 2017
3 Overlooked Drug Stocks to Watch Out for in 2017 Jan 03 2017
Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : January 2, 2017 Jan 02 2017
Blog Coverage Repligen Acquires Maker of Tangential Flow Filtration Cassettes Dec 16 2016
Novasep Sells U.S. Subsidiary TangenX Technology Corporation, Innovator in Tangential Flow... Dec 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)